America Great Health (AAGH) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Alhambra, CA, United States. The current CEO is Mike Qingkun Wang.
AAGH has IPO date of 2012-09-25, 5 full-time employees, listed on the Other OTC, a market capitalization of $2.12M.
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and the manufacturing and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health was founded in 2013 and is headquartered in Alhambra, California.
